Mesenchymal stromal cells (MSCs) possess profound immunomodulatory and regenerative
properties that are of clinical use in numerous clinical indications with unmet medical need …

Mesenchymal stromal cells (MSCs) represent a heterogeneous subset of multipotent cells
that can be isolated from several tissues including bone marrow and fat. MSCs exhibit …

Mesenchymal stromal cells (MSCs) comprise a heterogeneous population of multipotent
cells that can be isolated from various human tissues and culture-expanded ex vivo for …

Mesenchymal stromal cells (MSCs) are multipotent stem cells well known for repairing
tissue, supporting hematopoiesis, and modulating immune and inflammation response …

Because of their immunomodulatory and engraftment-promoting properties, mesenchymal
stromal cells (MSCs) have been tested in the clinical setting both to facilitate haematopoietic …

Mesenchymal stromal/stem cells (MSCs) possess immunomodulatory and reparative
properties. Through specific interactions with immune cells that participate in both innate …

Graft versus host disease (GvHD) is a life-threating complication of allogeneic hematopoietic
stem cell transplantation, which is initially treated with high dose corticosteroids …

Bone marrow-derived mesenchymal stromal cells (MSCs) represent a population of
nonhematopoietic cells, which play a crucial role in supporting hematopoiesis and can …

Mesenchymal stromal cells (MSC) are a population of phenotypically heterogeneous cells
that can be isolated from many readily accessible tissues, including bone marrow, umbilical …

Acute graft-versus-host disease (aGvHD) continues to impact morbidity and mortality after
allogeneic stem cell transplantation (allo-SCT). First-line therapy for aGvHD still remains the …